scispace - formally typeset
L

Laura Kerschke

Researcher at University of Münster

Publications -  27
Citations -  349

Laura Kerschke is an academic researcher from University of Münster. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 17 publications receiving 174 citations.

Papers
More filters
Journal ArticleDOI

A mechanistic classification of clinical phenotypes in neuroblastoma

TL;DR: This work sequenced more than 400 pretreatment neuroblastomas and identified molecular features that characterize the three distinct clinical outcomes, and proposed a mechanistic classification of neuroblastoma that may benefit the clinical management of patients.
Journal ArticleDOI

Diurnal variations in flow density measured using optical coherence tomography angiography and the impact of heart rate, mean arterial pressure and intraocular pressure on flow density in primary open‐angle glaucoma patients

TL;DR: To determine the diurnal variations in peripapillary and macular flow density, as measured using optical coherence tomography angiography (OCTA), and to elaborate on the relationship between diurnal FD, circulatory parameters and intraocular pressure (IOP) variations in primary open‐angle glaucoma (POAG).
Journal ArticleDOI

Influence of mydriasis on optical coherence tomography angiography imaging in patients with age-related macular degeneration.

TL;DR: A comparison of OCTA metrics from images taken with different pupil states (miosis versus mydriasis) is valid for clinical trials and since MAS improved significantly in dilation, mydriatic examination is recommended.
Journal ArticleDOI

Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial

TL;DR: A comparison of screening efficacy parameters resulting from DBT+s2D versus the current screening standard 2D full-field digital mammography (FFDM) in a multicentre and multivendor setting on the basis of the quality-controlled, population-based, biennial mammography screening programme in Germany is designed.
Journal ArticleDOI

Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial.

TL;DR: TOSYMA as mentioned in this paper was a randomized, open-label, superiority trial done at 17 screening units in two federal states of Germany, where women were randomly assigned to digital breast tomosynthesis plus s2D mammography or digital mammography alone using block randomisation.